Publications in collaboration with researchers from Universidade da Coruña (17)

2021

  1. Effectiveness to promote weight loss maintenance and healthy lifestyle habits of a group educational intervention program in adults with obesity: IGOBE program

    Obesity Research and Clinical Practice, Vol. 15, Núm. 6, pp. 570-578

  2. Epigenetic landscape in blood leukocytes following ketosis and weight loss induced by a very low calorie ketogenic diet (VLCKD) in patients with obesity

    Clinical Nutrition, Vol. 40, Núm. 6, pp. 3959-3972

2020

  1. Altered pathways in methylome and transcriptome longitudinal analysis of normal weight and bariatric surgery women

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. DNA methylation screening after roux-en y gastric bypass reveals the epigenetic signature stems from genes related to the surgery per se

    BMC Medical Genomics, Vol. 12, Núm. 1

2018

  1. Resting metabolic rate of obese patients under very low calorie ketogenic diet

    Nutrition and Metabolism, Vol. 15, Núm. 1

2017

  1. Body composition changes after very-low-calorie ketogenic diet in obesity evaluated by 3 standardized methods

    Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 2, pp. 488-498

  2. Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: A marker of metabolic stress?

    International Journal of Obesity, Vol. 41, Núm. 10, pp. 1570-1578

2006

  1. Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients

    Diabetes, Obesity and Metabolism, Vol. 8, Núm. 5, pp. 555-560

2004

  1. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients

    Clinical Endocrinology, Vol. 61, Núm. 2, pp. 250-255

2003

  1. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese hypopituitary patients

    European Journal of Endocrinology, Vol. 149, Núm. 2, pp. 117-122

  2. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients

    Clinical Endocrinology, Vol. 59, Núm. 4, pp. 431-436

2002

  1. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity

    Clinical Endocrinology, Vol. 56, Núm. 4, pp. 487-492

  2. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome

    Clinical Endocrinology, Vol. 57, Núm. 6, pp. 745-749

2001

  1. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients

    Clinical Endocrinology, Vol. 54, Núm. 4, pp. 509-513

1999

  1. Prevalence of pregnancy and postpartum thyroid dysfunction in a homogeneous population of Spain

    Gynecological Endocrinology, Vol. 13, Núm. 4, pp. 279-287

  2. Serum leptin levels in women throughout pregnancy and the postpartum period and in women suffering spontaneous abortion

    Clinical Endocrinology, Vol. 50, Núm. 2, pp. 211-216

1998

  1. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 12, pp. 4350-4354